Delivery Order SPE2DB22D3019-SPE2DB26FK2SP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,524.10 to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 200 mg capsules (30-count units) under a firm fixed-price contract type. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, and the product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction and is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 200 mg capsules (30-count units) under a firm fixed-price contract valued at $1,544.97. The delivery order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Tramadol HCL ER 100 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,383.34, with an ultimate completion date of April 24, 2025. The contract is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.83 to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 200 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.94 to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 200 mg tablets (30-count packages) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single fulfillment order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tramadol HCL ER 300 mg tablets (30-count units) on September 26, 2025, with a ceiling value of $2,547.62 and an ultimate completion date of September 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.09 to AmerisourceBergen Drug Corp for Tramadol HCL ER 100 mg capsules (30-count units) with a completion date of June 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Tramadol HCL 100 mg tablets (100-count units) valued at $1,170.20, with completion targeted for September 8, 2025. This non-competitive delivery order utilizes firm fixed-price terms and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 300 mg tablets (30-count) under a firm fixed-price contract valued at $1,868.10. The award, announced on September 10, 2025, with completion scheduled for September 11, 2025, was made without a set-aside designation through competitive procurement. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,949.19 to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 100 mg tablets in 30-count units. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB26FK2SPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 200 mg capsules (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $1,005.74 and is structured as a firm fixed price delivery order. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The delivery order reflects the ongoing operational needs of the Defense Health Agency and other federal healthcare beneficiaries for pain management pharmaceuticals through this expansive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/20/25 |